Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by forrest6748on Jun 09, 2021 8:08am
134 Views
Post# 33353793

THRM test still in request

THRM test still in request

Delta variant spread puts Boris Johnson in a tough spot, as he weighs whether U.K. should fully reopen

https://www.washingtonpost.com/world/europe/delta-variant-uk-reopening/2021/06/08/adb0aa5e-c7ca-11eb-8708-64991f2acf28_story.html

LONDON — Boris Johnson faces a life-or-death decision. That is not hyperbole. In the next few days, the British prime minister must decide whether to fully reopen society as planned, even as a new and highly infectious coronavirus variant surges.

 

Johnson will make this decision as British scientists — who are running one of the best genomic surveillance programs in the world — are telling him that the viral strain B.1.617.2, originally discovered in India and known now as the delta variant, is exploding, and that Britain could soon enter a dreaded third wave.


<< Previous
Bullboard Posts
Next >>